| Literature DB >> 110028 |
M Foglé-Hansson, H Rundcrantz.
Abstract
Thirty patients with allergic rhinoconjunctivitis were treated with eye drops containing 2% DSCG during the pollen season of 1977. Sixteen patients were treated with active substance and 14 with placebo. The results show a statistically significant difference in favour of the DSCG drops. DSCG in eye drops seems to be a valuable complement to the drugs available today for the treatment of allergic rhinoconjunctivitis.Entities:
Mesh：
Substances：
Year: 1979 PMID： 110028 DOI： 10.3109/00016487809123464
Source DB: PubMed Journal: Acta Otolaryngol Suppl ISSN： 0365-5237